Nasal COVID-19 vaccine halts transmission
Research on hamsters indicates that nasal COVID-19 vaccines targeting the nose and mouth may be key to controlling the spread of respiratory infections. …
Research on hamsters indicates that nasal COVID-19 vaccines targeting the nose and mouth may be key to controlling the spread of respiratory infections. …
COVID-19 vaccination was associated with moderate protection against long COVID in large, diverse cohort of children. …
Researchers found COVID-19 vaccination was associated with an average one-day shift in menstrual cycle length but was not significantly associated with changes in cycle regularity, bleed length, or pain. …
Scientists have identified the immune signature of post-COVID-19 vaccine heart inflammation cases. …
Gut bacteria that break down a sugar called fucose could be dampening our immune response to the COVID-19 vaccine. …
A new study has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system. …
Preclinical study finds the combination of the Moderna mRNA vaccine and a protein-based vaccine candidate containing an adjuvant elicits durable neutralizing antibody responses to SARS-CoV-2 in infant rhesus macaques. …
Among almost 43 million people in England who received at least one COVID-19 vaccine dose, the risk of myocarditis was
at least 11 times lower compared to unvaccinated individuals after COVID-19 infection. …
A new study found that the fourth dose of COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. …
Study provides the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. …
End of content
End of content